JP2019534296A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019534296A5 JP2019534296A5 JP2019523710A JP2019523710A JP2019534296A5 JP 2019534296 A5 JP2019534296 A5 JP 2019534296A5 JP 2019523710 A JP2019523710 A JP 2019523710A JP 2019523710 A JP2019523710 A JP 2019523710A JP 2019534296 A5 JP2019534296 A5 JP 2019534296A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- formula
- composition according
- group
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662419153P | 2016-11-08 | 2016-11-08 | |
| US62/419,153 | 2016-11-08 | ||
| PCT/EP2017/078486 WO2018087092A1 (en) | 2016-11-08 | 2017-11-07 | Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019534296A JP2019534296A (ja) | 2019-11-28 |
| JP2019534296A5 true JP2019534296A5 (enExample) | 2020-12-10 |
| JP7055802B2 JP7055802B2 (ja) | 2022-04-18 |
Family
ID=60421748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019523710A Active JP7055802B2 (ja) | 2016-11-08 | 2017-11-07 | 正常眼圧緑内障を処置するための一酸化窒素放出プロスタグランジン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11058691B2 (enExample) |
| JP (1) | JP7055802B2 (enExample) |
| KR (1) | KR20190104993A (enExample) |
| BR (1) | BR112019009330A2 (enExample) |
| CA (1) | CA3043000A1 (enExample) |
| MX (1) | MX2019005321A (enExample) |
| WO (1) | WO2018087092A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6750473B2 (ja) * | 2016-11-22 | 2020-09-02 | 沖電気工業株式会社 | 自動取引装置及び自動取引システム |
| CN117979973A (zh) | 2021-09-20 | 2024-05-03 | 尼科斯股份有限公司 | 作为神经保护剂的释放一氧化氮的前列腺酰胺 |
| CA3195291A1 (en) * | 2022-04-13 | 2023-10-13 | Caravel Therapeutics, Inc. | Preservative-free ophthalmic pharmaceutical emulsion and its application |
| WO2024121867A1 (en) * | 2022-12-09 | 2024-06-13 | Sentiss Pharma Private Limited | Pharmaceutical composition for glaucoma and ocular hypertension |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4952581A (en) | 1987-04-03 | 1990-08-28 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
| ES2105333T3 (es) | 1992-10-13 | 1997-10-16 | Alcon Lab Inc | Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma. |
| IT1295694B1 (it) | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
| KR100850133B1 (ko) * | 2004-01-05 | 2008-08-04 | 니콕스 에스. 에이. | 프로스타글란딘 나이트로옥시 유도체 |
| CA2613010A1 (en) | 2005-06-29 | 2007-01-04 | Pfizer Inc. | Fluoroprostaglandins nitroderivatives |
| WO2007000641A2 (en) | 2005-06-29 | 2007-01-04 | Pfizer Inc. | Prostaglandin derivatives |
| AR076731A1 (es) | 2008-05-09 | 2011-07-06 | Pfizer | Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas |
-
2017
- 2017-11-07 US US16/343,323 patent/US11058691B2/en active Active
- 2017-11-07 WO PCT/EP2017/078486 patent/WO2018087092A1/en not_active Ceased
- 2017-11-07 JP JP2019523710A patent/JP7055802B2/ja active Active
- 2017-11-07 CA CA3043000A patent/CA3043000A1/en active Pending
- 2017-11-07 MX MX2019005321A patent/MX2019005321A/es unknown
- 2017-11-07 KR KR1020197016230A patent/KR20190104993A/ko not_active Ceased
- 2017-11-07 BR BR112019009330A patent/BR112019009330A2/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019534296A5 (enExample) | ||
| JOP20220069A1 (ar) | عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها | |
| JP2020507589A5 (enExample) | ||
| JP2019510027A5 (enExample) | ||
| JP2018531233A5 (enExample) | ||
| JP2017523225A5 (enExample) | ||
| JP2019500387A5 (enExample) | ||
| JP2019535723A5 (enExample) | ||
| RU2018101473A (ru) | Депо-препарат, содержащий сложный эфир лимонной кислоты | |
| JP2014515383A5 (enExample) | ||
| JP2010514733A5 (enExample) | ||
| JP2005536531A5 (enExample) | ||
| JP2009040767A5 (enExample) | ||
| JP2003206241A5 (enExample) | ||
| JP2019151627A5 (enExample) | ||
| JP2009525970A5 (enExample) | ||
| RU2007101238A (ru) | Пептидные агонисты вазопрессинового рецептора | |
| JP2020511437A5 (enExample) | ||
| JP2019516726A5 (enExample) | ||
| JP2004538278A5 (enExample) | ||
| JP2019085364A5 (enExample) | ||
| JP2005513103A5 (enExample) | ||
| JP5420877B2 (ja) | 眼科用剤 | |
| TWI403324B (zh) | 醫藥組成物 | |
| JP2005047909A (ja) | ピペリジン誘導体を有効成分とする掻痒治療剤 |